Egalet Corp. (NASDAQ: EGLT) Starts Presentation at LD Micro Main Event
Egalet (NASDAQ: EGLT), a fully integrated specialty pharmaceutical company, is focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions. Egalet developed ARYMO® ER extended-release tablets C-II, an extended-release morphine product formulated with abuse-deterrent properties, which is marketed and approved for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. In addition, Egalet also markets two other innovative pain products: SPRIX® (ketorolac tromethamine) Nasal Spray, and OXAYDO® (oxycodone HCl, USP) Tablets for oral use only – CII. For more information, visit the company’s website at www. egalet.com. About NetworkNewsWire NetworkNewsWire (NNW) is an…







